A variety of research is underway at TRI, but in the past 3 years many projects have achieved results which qualify them as 'translational' research. The most successful projects at TRI collaborate across partners and disciplines, creating themes which we are collecting into flagship programs.
TRI currently hosts 4 flagship programs, each with a collection of related translational projects. By grouping these projects together we can identify where resources are needed or duplicated, and encourage collaboration between science and health. Conversations inspired by these programs have led to new projects identified such as Prof Carolyn Mountford's clinical imaging techniques to test Prof Ian Frazer's cancer immunotherapy treatment in clinical trials.
It could be said that TRI was built on immunotherapy, with many of the main translational projects in this program being underway since our official opening 3 years ago. The cervical cancer and rheumatoid arthritis vaccine projects are world class examples of the success of immunotherapy.
New to TRI with the appointment of CEO Professor Carolyn Mountford in 2014, a collection of imaging projects use diagnostic techniques to understand the gut/brain axis, high risk BRCA breast cancer changes, brain changes from PTSD and trauma from blast injury or full contact sports.
Recently we have identified a strong theme of work in the area of Microbiome research and are in the process of gathering information about these projects to inform a possible program.
Recently we have identified a strong theme of work in the area of gynecological cancer research and are in the process of gathering information about these projects to inform a possible program.
> More Information Coming Soon